SCHEMBL9402219

SCHEMBL9402219

CCCCc1nnc(SCc2ccccc2)n1Cc1ccc(N)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9402287 0.91 LMNA (0.51) —
SCHEMBL9402365 0.85 TLR7 (0.50) —
SCHEMBL9402270 0.84 ALDH1A1 (0.67) —
SCHEMBL9402239 0.82 ALDH1A1 (0.46) —
SCHEMBL9402189 0.80 AGTR1 (0.68) —
SCHEMBL9402206 0.80 AGTR1 (0.57) —
SCHEMBL11511765 0.79 NPC1 (0.53) —
SCHEMBL7409233 0.79 HTT (0.51) —
SCHEMBL9402500 0.78 AGTR1 (0.57) —
SCHEMBL9402209 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5336778-A Substituted triazoles as angiotensin II antagonists MERCK & CO., INC. (US) 1994-08-09 — — US disclosed
EP-0409332-A2 Substituted triazoles as angiotensin II antagonists MERCK & CO. INC. (US) 1991-01-23 — — EP disclosed
Send feedback